Glucuronidation: an important mechanism for detoxification of benzo[a]pyrene metabolites in aerodigestive tract tissues
about
sameAs
Pulmonary metabolism of resveratrol: in vitro and in vivo evidenceEffect of Inulin on Proteome Changes Induced by Pathogenic Lipopolysaccharide in Human ColonAnti-cancer drugs elicit re-expression of UDP-glucuronosyltransferases in melanoma cellsUDP-glucuronosyltransferase 1A determinates intracellular accumulation and anti-cancer effect of β-lapachone in human colon cancer cellsInterception of benzo[a]pyrene-7,8-dione by UDP glucuronosyltransferases (UGTs) in human lung cellsUrinary biomarkers of smokers' exposure to tobacco smoke constituents in tobacco products assessment: a fit for purpose approachInflammation-associated extracellular β-glucuronidase alters cellular responses to the chemical carcinogen benzo[a]pyreneEstrogen and cytochrome P450 1B1 contribute to both early- and late-stage head and neck carcinogenesisMeta-analysis reveals a lack of association between UGT2B17 deletion polymorphism and tumor susceptibility.UDP-glucuronosyltransferase 1A10: activity against the tobacco-specific nitrosamine, 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol, and a potential role for a novel UGT1A10 promoter deletion polymorphism in cancer susceptibility.The effect of UGT1A and UGT2B polymorphisms on colorectal cancer risk: haplotype associations and gene–environment interactions.Importance of UDP-glucuronosyltransferase 1A1 expression in skin and its induction by UVB in neonatal hyperbilirubinemiaCharacterization of UDP-glucuronosyltransferase 2A1 (UGT2A1) variants and their potential role in tobacco carcinogenesis.Polyphenol-rich extract from blackcurrant pomace attenuates the intestinal tract and serum lipid changes induced by a high-fat diet in rabbitsPotential role of UGT pharmacogenetics in cancer treatment and prevention: focus on tamoxifen and aromatase inhibitors.Ovarian susceptibility to benzo[a]pyrene: tissue burden of metabolites and DNA adducts in F-344 ratsPhospho-ibuprofen (MDC-917) is a novel agent against colon cancer: efficacy, metabolism, and pharmacokinetics in mouse models.Uridine 5'-diphospho-glucuronosyltransferase genetic polymorphisms and response to cancer chemotherapy.Pharmacogenomics of human UDP-glucuronosyltransferase enzymes.Characterization of dibenzo[a,l]pyrene-trans-11,12-diol (dibenzo[def,p]chrysene) glucuronidation by UDP-glucuronosyltransferases.Analysis of R- and S-hydroxywarfarin glucuronidation catalyzed by human liver microsomes and recombinant UDP-glucuronosyltransferasesCoordinate regulation of drug metabolism by xenobiotic nuclear receptors: UGTs acting together with CYPs and glucuronide transporters.Quantification of Hepatic UDP glucuronosyltransferase 1A splice variant expression and correlation of UDP glucuronosyltransferase 1A1 variant expression with glucuronidation activityRole of human UDP-glucuronosyltransferases in the biotransformation of the triazoloacridinone and imidazoacridinone antitumor agents C-1305 and C-1311: highly selective substrates for UGT1A10Germline copy number loss of UGT2B28 and gain of PLEC contribute to increased human esophageal squamous cell carcinoma risk in Southwest China.Glucuronides in the gut: Sugar-driven symbioses between microbe and host.Identification and functional characterization of a novel UDP-glucuronosyltransferase 2A1 splice variant: potential importance in tobacco-related cancer susceptibility.Association between UGT1A1 Polymorphism and Risk of Laryngeal Squamous Cell Carcinoma.Disposition of flavonoids via enteric recycling: determination of the UDP-glucuronosyltransferase isoforms responsible for the metabolism of flavonoids in intact Caco-2 TC7 cells using siRNA.Functional significance of UDP-glucuronosyltransferase variants in the metabolism of active tamoxifen metabolitesPotential role of UGT pharmacogenetics in cancer treatment and prevention: focus on tamoxifen.Genetic polymorphism in metabolism and host defense enzymes: implications for human health risk assessment.Gilbert syndrome: the UGT1A1*28 promoter polymorphism as a biomarker of multifactorial diseases and drug metabolism.Transcriptional regulation of human UDP-glucuronosyltransferase genes.Genetic polymorphisms of human UDP-glucuronosyltransferase (UGT) genes and cancer risk.Expression of UDP-glucuronosyltransferase 1A in bladder cancer: association with prognosis and regulation by estrogen.Androgen receptor signals regulate UDP-glucuronosyltransferases in the urinary bladder: a potential mechanism of androgen-induced bladder carcinogenesis.Characterization of UGTs active against SAHA and association between SAHA glucuronidation activity phenotype with UGT genotype.Androgen-stimulated UDP-glucose dehydrogenase expression limits prostate androgen availability without impacting hyaluronan levels.Dopamine is a low-affinity and high-specificity substrate for the human UDP-glucuronosyltransferase 1A10.
P2860
Q24633218-72156BA0-27A0-478F-B4AC-EFCA2212BE94Q28469369-94A80612-496F-44AA-A86F-D094F5868085Q28484515-53B9EBD9-696D-43EC-85B6-B1AF5201B2F8Q28543502-740F7862-2836-49DC-9C56-CD5B3FF0A418Q28661585-66A02BD4-CED1-4DAD-9B19-43FB792E8676Q28662000-81519E41-014F-466C-AEDE-A61867EBECA4Q28830448-C4C80AC0-301E-4DCF-96C8-B636574593CAQ30498225-41697280-D575-477B-86B9-5C9BE27F62FCQ33573400-9DABC23F-AE91-415D-9281-DBE41A408F0CQ33714575-F4FE68A6-849F-46F3-BDFF-D427A2EFA64BQ33724160-24E0C4BF-0149-474E-BC41-0A046E0CC5D2Q34364347-EB6FEABF-E05A-48B0-A4A5-DFB840205B86Q34482453-760CDC88-6A6A-4E38-B1F1-BC6FB9A7C30FQ34567366-BEC28B58-1661-42CE-9618-1FDF131CA954Q34774040-0859B8D7-D18A-4677-AAD1-7972800E383CQ34799433-C0139D8D-DBBB-4335-84D7-58AAD7681C62Q35003113-F4A14E99-6C77-4841-81AD-B55F39DDD8D5Q35008045-C65B7353-9FC1-437C-BB68-A1C2C966AD31Q35157993-C02995D9-301E-48EF-AAC2-7FA179E45906Q35226246-535683A9-90D6-40F1-995C-BADACF70C13DQ35650772-C8461DA7-74DB-433E-A3AA-413AB0EF5FC2Q35956173-1F71D05A-788A-49F7-B646-55C6BA1FDABAQ36174174-6FD77D26-B7C9-4FA1-B0CE-4A1A321688BBQ36174250-1869C427-B4FE-4D3F-A78D-81ED82CB3764Q36309393-DE303C42-97F1-4836-9A9E-F0A8EEADF51FQ36340552-227DFF5D-DEB5-4B61-85D0-78148D5CC2AEQ36406279-5423E093-A6DE-4821-AA9C-83BAB45D42CFQ36513227-B3E04112-9761-416C-B60B-ECA2FBB5B21DQ37003179-8B2D6E63-5F80-43DF-8EFC-7C37CF38DBFEQ37195375-E5A47005-48AC-4475-8B45-D5EAC8CC89DFQ37221922-B99FDE1C-54E7-4D95-9462-BCCE0A4AF17CQ37775981-88287C2B-E501-4CD4-884E-E987582A4ACCQ37997047-0DC928BA-ACF9-4F34-B345-00E516BBBD00Q38261875-49D31D02-39AE-4C01-B04E-F1C44740B28BQ38717288-4536EDE0-37BC-411B-B1AF-EB7F1AF708C1Q39246454-50105C67-4BFB-41FD-81F6-03015A378665Q39442380-AE37ED1F-C0B0-4A9E-BAF6-27FE2422F82BQ39868674-927D1003-BDBA-47C3-A1C0-CECD0EF1B4C8Q39879669-CB7B9232-E531-41E6-8240-562A7B390A63Q43129902-D04292A5-C0DA-4BF0-977C-E514128EF65D
P2860
Glucuronidation: an important mechanism for detoxification of benzo[a]pyrene metabolites in aerodigestive tract tissues
description
2002 nî lūn-bûn
@nan
2002 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Glucuronidation: an important ...... in aerodigestive tract tissues
@ast
Glucuronidation: an important ...... in aerodigestive tract tissues
@en
Glucuronidation: an important ...... in aerodigestive tract tissues
@nl
type
label
Glucuronidation: an important ...... in aerodigestive tract tissues
@ast
Glucuronidation: an important ...... in aerodigestive tract tissues
@en
Glucuronidation: an important ...... in aerodigestive tract tissues
@nl
prefLabel
Glucuronidation: an important ...... in aerodigestive tract tissues
@ast
Glucuronidation: an important ...... in aerodigestive tract tissues
@en
Glucuronidation: an important ...... in aerodigestive tract tissues
@nl
P2093
P356
P1476
Glucuronidation: an important ...... in aerodigestive tract tissues
@en
P2093
Jia-Long Fang
Philip Lazarus
Zhong Zheng
P304
P356
10.1124/DMD.30.4.397
P407
P577
2002-04-01T00:00:00Z